cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Century Therapeutics Inc
3 own
1 watching
Current Price
$4.18
$-0.09
(-2.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
264.54M
52-Week High
52-Week High
5.51000
52-Week Low
52-Week Low
1.28000
Average Volume
Average Volume
0.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization264.54M
icon52-Week High5.51000
icon52-Week Low1.28000
iconAverage Volume0.17M
iconDividend Yield--
iconP/E Ratio--
What does the Century Therapeutics Inc do?
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company s lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.
Read More
How much money does Century Therapeutics Inc make?
News & Events about Century Therapeutics Inc.
Benzinga
11 months ago
Latest Ratings for IPSC DateFirmActionFromTo Nov 2021SVB LeerinkMaintainsOutperform Jul 2021B of A SecuritiesInitiates Coverage OnBuy Jul 2021SVB LeerinkInitiates Coverage OnOutperform View More Analyst Ratings for IPSC View the Latest Analyst Ratings read more...
Globe Newswire
11 months ago
Lalo Flores, Ph.D., steps down as Chief Executive Officer and member of Board of Directors; Greg Russotti, Ph.D., Chief Technology Officer, assumes role of ad-interim Chief Executive Officer Michael C. Diem, M.D., promoted to Chief Financial Officer Hy Levitsky, M.D., rejoins as President of ...
Zolmax
1 year ago
Century Therapeutics, Inc. (NASDAQ:IPSC Get Rating) insider Luis Borges sold 63,616 shares of the firms stock in a transaction dated Tuesday, March 21st. The shares were sold at an average price of $3.77, for a total transaction of $239,832.32. Following the completion of the transaction, the ...
Ticker Report
1 year ago
Century Therapeutics, Inc. (NASDAQ:IPSC Get Rating) insider Luis Borges sold 63,616 shares of the firms stock in a transaction dated Tuesday, March 21st. The shares were sold at an average price of $3.77, for a total transaction of $239,832.32. Following the completion of the ...
Globe Newswire
1 year ago
- Phase 1 ELiPSE-1 trial of CNTY-101 in relapsed/refractory CD19 positive B-cell lymphomas underway - - Ended 2022 with cash, cash equivalents, and investments of $367.4 million; Cash runway expected into 2026 PHILADELPHIA, March 16, 2023 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (NASDAQ: IPSC...
Frequently Asked Questions
Frequently Asked Questions
What is Century Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Century Therapeutics Inc shares?
plus_minus_icon
How can I buy Century Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Century Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Century Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Century Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Century Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Century Therapeutics Inc?
plus_minus_icon
What percentage is Century Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Century Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.18
$-0.09
(-2.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00